Maxiflo forte rotacaps

Description

Maxiflo Forte Rotacaps is a combination inhalation medication designed to treat asthma and chronic obstructive pulmonary disease (COPD). It contains Fluticasone Propionate (500 mcg), a potent corticosteroid that reduces airway inflammation, and Salmeterol Xinafoate (50 mcg), a long-acting bronchodilator that helps relax airway muscles for improved airflow.

Key Features:
Active Ingredients:
Fluticasone Propionate (500 mcg): Reduces airway inflammation, preventing asthma flare-ups and COPD exacerbations.
Salmeterol Xinafoate (50 mcg): A long-acting bronchodilator that improves airflow by relaxing the muscles around the airways.
Rotacap Format: Capsules designed for use with the Rotahaler device, ensuring accurate dosing and effective medication delivery.
Dual Action: Provides both anti-inflammatory and bronchodilatory effects for comprehensive management of asthma and COPD.
30 Capsules per Pack: Ideal for long-term treatment and maintenance of respiratory conditions.

Benefits:
Improves lung function and makes breathing easier
Reduces inflammation in the airways and prevents bronchospasms
Helps in the management and prevention of asthma and COPD symptoms
Long-lasting relief with improved control over respiratory conditions

Specifications:
Dosage: 500 mcg Fluticasone + 50 mcg Salmeterol per rotacap
Quantity: 30 capsules
Recommended Usage: As prescribed by a healthcare provider, typically 1 capsule per day using the Rotahaler device.
For Use With: Rotahaler device